Cholesterol efflux capacity is a proinflammatory factor associated with atherosclerosis: a lower cholesterol efflux is negatively associated with the elevation of many proinflammatory molecules, including CRP, fibrinogen, interleukin-6 (IL-6), and serum amyloid A, and positively associated with cardiovascular mortality [43]. This evidence concerns the gene IL6 and atherosclerosis.